Connor, Clark & Lunn Investment Management (CC&L)
RETA

Connor, Clark & Lunn Investment Management (CC&L)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,842
Closed -$550K – 1266
2021
Q4 		$550K Buy
20,842
+12,047
+137% +$318K ﹤0.01% 782
2021
Q3 		$885K Buy
+8,795
New +$885K ﹤0.01% 667